[HTML][HTML] The 5th edition of the World Health Organization classification of haematolymphoid tumours: lymphoid neoplasms
We herein present an overview of the upcoming 5th edition of the World Health Organization
Classification of Haematolymphoid Tumours focussing on lymphoid neoplasms. Myeloid …
Classification of Haematolymphoid Tumours focussing on lymphoid neoplasms. Myeloid …
[HTML][HTML] T cell receptor (TCR) signaling in health and disease
Interaction of the T cell receptor (TCR) with an MHC-antigenic peptide complex results in
changes at the molecular and cellular levels in T cells. The outside environmental cues are …
changes at the molecular and cellular levels in T cells. The outside environmental cues are …
Distinction of lymphoid and myeloid clonal hematopoiesis
Clonal hematopoiesis (CH) results from somatic genomic alterations that drive clonal
expansion of blood cells. Somatic gene mutations associated with hematologic …
expansion of blood cells. Somatic gene mutations associated with hematologic …
[HTML][HTML] Role of PI3K/AKT pathway in cancer: the framework of malignant behavior
N Jiang, Q Dai, X Su, J Fu, X Feng, J Peng - Molecular biology reports, 2020 - Springer
Given that the PI3K/AKT pathway has manifested its compelling influence on multiple
cellular process, we further review the roles of hyperactivation of PI3K/AKT pathway in …
cellular process, we further review the roles of hyperactivation of PI3K/AKT pathway in …
Genomic profiling for clinical decision making in lymphoid neoplasms
L De Leval, AA Alizadeh, PL Bergsagel… - Blood, The Journal …, 2022 - ashpublications.org
With the introduction of large-scale molecular profiling methods and high-throughput
sequencing technologies, the genomic features of most lymphoid neoplasms have been …
sequencing technologies, the genomic features of most lymphoid neoplasms have been …
Subtype-specific 3D genome alteration in acute myeloid leukaemia
Acute myeloid leukaemia (AML) represents a set of heterogeneous myeloid malignancies,
and hallmarks include mutations in epigenetic modifiers, transcription factors and kinases …
and hallmarks include mutations in epigenetic modifiers, transcription factors and kinases …
CTLA-4: a moving target in immunotherapy
B Rowshanravan, N Halliday… - Blood, The Journal of …, 2018 - ashpublications.org
CD28 and CTLA-4 are members of a family of immunoglobulin-related receptors that are
responsible for various aspects of T-cell immune regulation. The family includes CD28 …
responsible for various aspects of T-cell immune regulation. The family includes CD28 …
[PDF][PDF] Interaction of tau with HNRNPA2B1 and N6-methyladenosine RNA mediates the progression of tauopathy
The microtubule-associated protein tau oligomerizes, but the actions of oligomeric tau
(oTau) are unknown. We have used Cry2-based optogenetics to induce tau oligomers (oTau …
(oTau) are unknown. We have used Cry2-based optogenetics to induce tau oligomers (oTau …
Highly immunogenic cancer cells require activation of the WNT pathway for immunological escape
Y Takeuchi, T Tanegashima, E Sato, T Irie, A Sai… - Science …, 2021 - science.org
PD-1 blockade exerts antitumor effects by reinvigorating tumor antigen–specific CD8+ T
cells. Whereas neoantigens arising from gene alterations in cancer cells comprise critical …
cells. Whereas neoantigens arising from gene alterations in cancer cells comprise critical …
Autophagy as a molecular target for cancer treatment
Autophagy is an evolutionarily conserved catabolic mechanism, by which eukaryotic cells
recycle or degrades internal constituents through membrane-trafficking pathway. Thus …
recycle or degrades internal constituents through membrane-trafficking pathway. Thus …